» Articles » PMID: 29749132

Prognostic Value of MicroRNAs in Coronary Artery Diseases: A Meta-Analysis

Overview
Journal Yonsei Med J
Specialty General Medicine
Date 2018 May 12
PMID 29749132
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Coronary artery diseases (CADs) are the leading causes of death in the world. Recent studies have reported that differentially expressed microRNAs (miRNAs) are associated with prognosis or major adverse cardiac events (MACEs) in CAD patients. In a previous meta-analysis, the authors made serious mistakes that we aimed to correct through an updated systematic review and meta-analysis of the prognostic value of altered miRNAs in patients with CADs.

Materials And Methods: We performed a systematic search of MEDLINE (from inception to May 2017) and EMBASE (from inception to May 2017) for English-language publications. Studies of CADs with results on miRNAs that reported survival data or MACEs were included. Data were extracted from each publication independently by two reviewers.

Results: After reviewing 515 articles, a total eight studies were included in this study. We measured pooled hazard ratios (HRs) and 95% confidence intervals (CIs) of miRNA 133a with a fixed-effect model (pooled HR, 2.35; 95% CI, 1.56-3.55). High expression of miRNA 133a, 208b, 126, 197, 223, and 122-5p were associated with high mortality. Additionally, high levels of miRNA 208b, 499-5p, 134, 328, and 34a were related with MACEs.

Conclusion: The present study confirmed that miRNA 133a, which was associated with high mortality in CAD patients, holds prognostic value in CAD. More importantly, this study corrected issues raised against a prior meta-analysis and provides accurate information.

Citing Articles

Protective Effects of NaHS/miR-133a-3p on Lipopolysaccharide-Induced Cardiomyocytes Injury.

Jin Y, Huang A, Yu M, Ye W, Hu X, Wang H J Toxicol. 2023; 2023:2566754.

PMID: 38106638 PMC: 10723929. DOI: 10.1155/2023/2566754.


Atherosclerosis and Its Related Laboratory Biomarkers.

Della Corte V, Todaro F, Cataldi M, Tuttolomondo A Int J Mol Sci. 2023; 24(21).

PMID: 37958528 PMC: 10649778. DOI: 10.3390/ijms242115546.


Dysregulation of Inflammation, Oxidative Stress, and Glucose Metabolism-Related Genes and miRNAs in Visceral Adipose Tissue of Women with Type 2 Diabetes Mellitus.

Wroblewski A, Strycharz J, Oszajca K, Czarny P, Swiderska E, Matyjas T Med Sci Monit. 2023; 29:e939299.

PMID: 37422695 PMC: 10340125. DOI: 10.12659/MSM.939299.


The Profile of Circulating Blood microRNAs in Outpatients with Vulnerable and Stable Atherosclerotic Plaques: Associations with Cardiovascular Risks.

Rozhkov A, Shchekochikhin D, Ashikhmin Y, Mitina Y, Evgrafova V, Zhelankin A Noncoding RNA. 2022; 8(4).

PMID: 35893230 PMC: 9326687. DOI: 10.3390/ncrna8040047.


microRNAs signatures as potential biomarkers of structural cardiotoxicity in human-induced pluripotent stem-cell derived cardiomyocytes.

Gryshkova V, Lushbough I, Palmer J, Burrier R, Delaunois A, Donley E Arch Toxicol. 2022; 96(7):2033-2047.

PMID: 35488128 DOI: 10.1007/s00204-022-03280-8.


References
1.
Cao W, Guo Q, Zhang T, Zhong D, Yu Q . Prognostic value of microRNAs in acute myocardial infarction: A systematic review and meta-analysis. Int J Cardiol. 2015; 189:79-84. DOI: 10.1016/j.ijcard.2015.04.055. View

2.
Huang W . MicroRNAs: Biomarkers, Diagnostics, and Therapeutics. Methods Mol Biol. 2017; 1617:57-67. DOI: 10.1007/978-1-4939-7046-9_4. View

3.
Wu Z, Wang C, Xiang R, Liu X, Ye S, Yang X . Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer. 2012; 12:51. PMC: 3297527. DOI: 10.1186/1471-2407-12-51. View

4.
Olivieri F, Antonicelli R, Spazzafumo L, Santini G, Rippo M, Galeazzi R . Admission levels of circulating miR-499-5p and risk of death in elderly patients after acute non-ST elevation myocardial infarction. Int J Cardiol. 2014; 172(2):e276-8. DOI: 10.1016/j.ijcard.2013.12.203. View

5.
Ke-Gang J, Zhi-Wei L, Xin Z, Jing W, Ping S, Xue-Jing H . Evaluating Diagnostic and Prognostic Value of Plasma miRNA133a in Acute Chest Pain Patients Undergoing Coronary Angiography. Medicine (Baltimore). 2016; 95(17):e3412. PMC: 4998688. DOI: 10.1097/MD.0000000000003412. View